ADJUTEC PHARMA AS

0379 OSLO

Finances

Return on Equity

−62,14 %

Current Ratio

4,06

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	7 842 000	6 278 000	0	0
Net Income	−17 151 000	−3 516 000	−747 000	0
Total Assets	33 992 000	32 987 000	1 541 000	30 000
Total Equity	27 601 000	32 760 000	1 277 000	24 000

Income (NOK)	2022	2021	2020
Revenue	7 842 000	6 278 000	0
Expenditure	31 237 000	11 493 000	747 000
Operating Profit	−23 395 000	−5 216 000	−747 000
Financial Income	275 000	95 000	0
Financial Costs	103 000	278 000	0
Financial Balance	172 000	−183 000	0
Earnings Before Tax	−23 222 000	−5 399 000	−747 000
Tax	−6 072 000	−1 883 000	0
Net Income	−17 151 000	−3 516 000	−747 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	8 029 000	1 883 000	0	0
Total Current Assets	25 963 000	31 104 000	1 541 000	30 000
Total Assets	33 992 000	32 987 000	1 541 000	30 000
Total Retained Equity	−21 414 000	−4 263 000	−747 000	0
Total Equity	27 601 000	32 760 000	1 277 000	24 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	6 391 000	227 000	263 000	6 000
Total Equity and Debt	33 992 000	32 987 000	1 541 000	30 000

Cash flow (NOK)	2022	2021	2020
Sales Income	0	0	0
Other Income	7 842 000	6 278 000	0
Revenue	7 842 000	6 278 000	0
Cost of Goods Sold	0	1 134 000	0
Salary Costs	5 157 000	1 631 000	0
Depreciation	0	0	0
Impairment	0	0	0
Expenditure	31 237 000	11 493 000	747 000
Operating Profit	−23 395 000	−5 216 000	−747 000
Financial Income	275 000	95 000	0
Financial Costs	103 000	278 000	0
Financial Balance	172 000	−183 000	0
Dividends	0	0	0
Net Income	−17 151 000	−3 516 000	−747 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	7 954 000	1 883 000	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	75 000	0	0	0
Total Fixed Assets	8 029 000	1 883 000	0	0
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	25 638 000	23 855 000	1 520 000	30 000
Total Current Assets	25 963 000	31 104 000	1 541 000	30 000
Total Assets	33 992 000	32 987 000	1 541 000	30 000
Total Equity	27 601 000	32 760 000	1 277 000	24 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	7 869 000	2 419 000	249 000	0
Unpaid Taxes	407 000	230 000	0	0
Dividends	0	0	0	0
Other Current Debt	2 865 000	201 000	15 000	6 000
Total Current Debt	6 391 000	227 000	263 000	6 000
Total Equity and Debt	33 992 000	32 987 000	1 541 000	30 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−62,14 %	−10,73 %	−58,5 %	0 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	−298,33 %	−83,08 %	-	-
Current Ratio	4,06	137,02	5,86	5
Quick Ratio	4,06	137,02	5,86	5
Equity Ratio	0,81	0,99	0,83	0,8
Gross Profit Margin	100 %	81,94 %	-	-